New York State Common Retirement Fund’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.91M | Buy |
148,722
+22,754
| +18% | +$557K | ﹤0.01% | 1232 |
|
|
2025
Q4 | $3.37M | Buy |
125,968
+35,799
| +40% | +$922K | ﹤0.01% | 1190 |
|
|
2025
Q3 | $2.4M | Buy |
90,169
+41,800
| +86% | +$1.08M | ﹤0.01% | 1372 |
|
|
2025
Q2 | $1.11M | Sell |
48,369
-33,196
| -41% | -$824K | ﹤0.01% | 1623 |
|
|
2025
Q1 | $2.36M | Buy |
81,565
+11,075
| +16% | +$354K | ﹤0.01% | 1315 |
|
|
2024
Q4 | $2.62M | Hold |
70,490
| – | – | ﹤0.01% | 1322 |
|
|
2024
Q3 | $3.42M | Buy |
70,490
+4,763
| +7% | +$209K | ﹤0.01% | 1232 |
|
|
2024
Q2 | $2.63M | Buy |
65,727
+11,738
| +22% | +$486K | ﹤0.01% | 1373 |
|
|
2024
Q1 | $2.37M | Buy |
53,989
+301
| +0.6% | +$15.5K | ﹤0.01% | 1403 |
|
|
2023
Q4 | $3.32M | Buy |
53,688
+5,361
| +11% | +$282K | ﹤0.01% | 1261 |
|
|
2023
Q3 | $2.22M | Sell |
48,327
-14,789
| -23% | -$807K | ﹤0.01% | 1405 |
|
|
2023
Q2 | $3.63M | Buy |
63,116
+3,330
| +6% | +$148K | ﹤0.01% | 1293 |
|
|
2023
Q1 | $2.24M | Buy |
59,786
+31,253
| +110% | +$1.02M | ﹤0.01% | 1494 |
|
|
2022
Q4 | $799K | Buy |
28,533
+1,787
| +7% | +$51.9K | ﹤0.01% | 2079 |
|
|
2022
Q3 | $752K | Buy |
26,746
+142
| +0.5% | +$4.64K | ﹤0.01% | 2118 |
|
|
2022
Q2 | $926K | Buy |
26,604
+204
| +0.8% | +$7.28K | ﹤0.01% | 2057 |
|
|
2022
Q1 | $948K | Sell |
26,400
-304
| -1% | -$8.62K | ﹤0.01% | 2130 |
|
|
2021
Q4 | $622K | Sell |
26,704
-94
| -0.4% | -$1.92K | ﹤0.01% | 2327 |
|
|
2021
Q3 | $509K | Sell |
26,798
-5,606
| -17% | -$110K | ﹤0.01% | 2456 |
|
|
2021
Q2 | $653K | Buy |
32,404
+304
| +0.9% | +$5.73K | ﹤0.01% | 2453 |
|
|
2021
Q1 | $588K | Hold |
32,100
| – | – | ﹤0.01% | 2375 |
|
|
2020
Q4 | $646K | Hold |
32,100
| – | – | ﹤0.01% | 2223 |
|
|
2020
Q3 | $602K | Hold |
32,100
| – | – | ﹤0.01% | 2126 |
|
|
2020
Q2 | $721K | Hold |
32,100
| – | – | ﹤0.01% | 2042 |
|
|
2020
Q1 | $476K | Hold |
32,100
| – | – | ﹤0.01% | 2065 |
|
|
2019
Q4 | $619K | Sell |
32,100
-5,800
| -15% | -$111K | ﹤0.01% | 2181 |
|
|
2019
Q3 | $752K | Sell |
37,900
-13,289
| -26% | -$277K | ﹤0.01% | 2126 |
|
|
2019
Q2 | $1.08M | Hold |
51,189
| – | – | ﹤0.01% | 1973 |
|
|
2019
Q1 | $1.05M | Buy |
51,189
+3,003
| +6% | +$67.3K | ﹤0.01% | 1938 |
|
|
2018
Q4 | $959K | Buy |
48,186
+10,286
| +27% | +$203K | ﹤0.01% | 1935 |
|
|
2018
Q3 | $729K | Sell |
37,900
-4,820
| -11% | -$85.9K | ﹤0.01% | 2251 |
|
|
2018
Q2 | $652K | Hold |
42,720
| – | – | ﹤0.01% | 2334 |
|
|
2018
Q1 | $801K | Hold |
42,720
| – | – | ﹤0.01% | 2144 |
|
|
2017
Q4 | $822K | Hold |
42,720
| – | – | ﹤0.01% | 2141 |
|
|
2017
Q3 | $763K | Hold |
42,720
| – | – | ﹤0.01% | 2153 |
|
|
2017
Q2 | $763K | Sell |
42,720
-1
| -0% | -$16 | ﹤0.01% | 2195 |
|
|
2017
Q1 | $619K | Buy |
42,721
+401
| +0.9% | +$6.3K | ﹤0.01% | 2289 |
|
|
2016
Q4 | $780K | Hold |
42,320
| – | – | ﹤0.01% | 2167 |
|
|
2016
Q3 | $803K | Buy |
42,320
+9,720
| +30% | +$176K | ﹤0.01% | 2100 |
|
|
2016
Q2 | $526K | Hold |
32,600
| – | – | ﹤0.01% | 2258 |
|
|
2016
Q1 | $391K | Hold |
32,600
| – | – | ﹤0.01% | 2347 |
|
|
2015
Q4 | $464K | Hold |
32,600
| – | – | ﹤0.01% | 2361 |
|
|
2015
Q3 | $381K | Buy |
32,600
+8,219
| +34% | +$123K | ﹤0.01% | 2440 |
|
|
2015
Q2 | $429K | Buy |
+24,381
| New | +$380K | ﹤0.01% | 2584 |
|
Other funds holding AMPH
VCM
BTW
New York State Common Retirement Fund's AMPH Position: Q1 2026 in Review
New York State Common Retirement Fund increased its Amphastar Pharmaceuticals (AMPH) stake by 18% in Q1 2026, buying an estimated $557K and bringing the position to 148,722 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1232.
New York State Common Retirement Fund first reported a position in AMPH in Q2 2015 and has held it in 44 quarters since. The position peaked at $3.63M in Q2 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- New York State Common Retirement Fund held 148,722 shares of Amphastar Pharmaceuticals worth $2.91M as of Q1 2026.
- New York State Common Retirement Fund bought 22,754 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $557K.
- Amphastar Pharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #1232 holding.
- New York State Common Retirement Fund first reported a position in Amphastar Pharmaceuticals in Q2 2015 and has held it in 44 quarters since.
- New York State Common Retirement Fund's Amphastar Pharmaceuticals position peaked at $3.63M in Q2 2023.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.